From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic.
Identifieur interne : 000F70 ( PubMed/Corpus ); précédent : 000F69; suivant : 000F71From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic.
Auteurs : M-Y Yen ; A W-H Chiu ; J. Schwartz ; C-C King ; Y E Lin ; S-C Chang ; D. Armstrong ; P-R HsuehSource :
- The Journal of hospital infection [ 1532-2939 ] ; 2014.
English descriptors
- KwdEn :
- Civil Defense (methods), Civil Defense (organization & administration), Communicable Disease Control (methods), Communicable Disease Control (organization & administration), Humans, Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza, Human (epidemiology), Influenza, Human (virology), Pandemics (prevention & control), Severe Acute Respiratory Syndrome (epidemiology), Taiwan (epidemiology).
- MESH :
- geographic , epidemiology : Taiwan.
- epidemiology : Influenza, Human, Severe Acute Respiratory Syndrome.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- methods : Civil Defense, Communicable Disease Control.
- organization & administration : Civil Defense, Communicable Disease Control.
- prevention & control : Pandemics.
- virology : Influenza, Human.
- Humans.
Abstract
In anticipation of a future pandemic potentially arising from H5N1, H7N9 avian influenza or Middle East Respiratory Syndrome, and in large part in response to severe acute respiratory syndrome (SARS) in 2003, the city of Taipei, Taiwan, has developed extensive new strategies to manage pandemics. These strategies were tested during the 2009 H1N1 outbreak. This article assesses pandemic preparedness in Taipei in the wake of recent pandemic experiences in order to draw lessons relevant to the broader international public health community. Drawing on Taiwan and Taipei Centers for Disease Control data on pandemic response and control, we evaluated the effectiveness of the changes in pandemic response policies developed by these governments over time, emphasizing hospital and medical interventions with particular attention paid to Traffic Control Bundling. SARS and H1N1 2009 catalysed the Taiwan and Taipei CDCs to continuously improve and adjust their strategies for a future pandemic. These new strategies for pandemic response and control have been largely effective at providing interim pandemic containment and control, while development and implementation of an effective vaccination programme is underway. As Taipei's experiences with these cases illustrate, in mitigating moderate or severe pandemic influenza, a graduated process including Traffic Control Bundles accompanied by hospital and medical interventions, as well as school- and community-focused interventions, provides an effective interim response while awaiting vaccine development. Once a vaccine is developed, to maximize pandemic control effectiveness, it should be allocated with priority given to vulnerable groups, healthcare workers and school children.
DOI: 10.1016/j.jhin.2014.05.005
PubMed: 24996515
Links to Exploration step
pubmed:24996515Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic.</title>
<author><name sortKey="Yen, M Y" sort="Yen, M Y" uniqKey="Yen M" first="M-Y" last="Yen">M-Y Yen</name>
<affiliation><nlm:affiliation>Section of Infectious Diseases, Taipei City Hospital, Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. Electronic address: myyen1121@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chiu, A W H" sort="Chiu, A W H" uniqKey="Chiu A" first="A W-H" last="Chiu">A W-H Chiu</name>
<affiliation><nlm:affiliation>Department of Surgery, Taipei City Hospital, Department of Health, Taipei City Government and National Yang-Ming University School of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schwartz, J" sort="Schwartz, J" uniqKey="Schwartz J" first="J" last="Schwartz">J. Schwartz</name>
<affiliation><nlm:affiliation>Department of Political Science, State University of New York, New Paltz, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="King, C C" sort="King, C C" uniqKey="King C" first="C-C" last="King">C-C King</name>
<affiliation><nlm:affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lin, Y E" sort="Lin, Y E" uniqKey="Lin Y" first="Y E" last="Lin">Y E Lin</name>
<affiliation><nlm:affiliation>Center for Environmental Laboratory Services, National Kaohsiung Normal University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chang, S C" sort="Chang, S C" uniqKey="Chang S" first="S-C" last="Chang">S-C Chang</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Armstrong, D" sort="Armstrong, D" uniqKey="Armstrong D" first="D" last="Armstrong">D. Armstrong</name>
<affiliation><nlm:affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, P R" sort="Hsueh, P R" uniqKey="Hsueh P" first="P-R" last="Hsueh">P-R Hsueh</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24996515</idno>
<idno type="pmid">24996515</idno>
<idno type="doi">10.1016/j.jhin.2014.05.005</idno>
<idno type="wicri:Area/PubMed/Corpus">000F70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F70</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic.</title>
<author><name sortKey="Yen, M Y" sort="Yen, M Y" uniqKey="Yen M" first="M-Y" last="Yen">M-Y Yen</name>
<affiliation><nlm:affiliation>Section of Infectious Diseases, Taipei City Hospital, Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. Electronic address: myyen1121@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chiu, A W H" sort="Chiu, A W H" uniqKey="Chiu A" first="A W-H" last="Chiu">A W-H Chiu</name>
<affiliation><nlm:affiliation>Department of Surgery, Taipei City Hospital, Department of Health, Taipei City Government and National Yang-Ming University School of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schwartz, J" sort="Schwartz, J" uniqKey="Schwartz J" first="J" last="Schwartz">J. Schwartz</name>
<affiliation><nlm:affiliation>Department of Political Science, State University of New York, New Paltz, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="King, C C" sort="King, C C" uniqKey="King C" first="C-C" last="King">C-C King</name>
<affiliation><nlm:affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lin, Y E" sort="Lin, Y E" uniqKey="Lin Y" first="Y E" last="Lin">Y E Lin</name>
<affiliation><nlm:affiliation>Center for Environmental Laboratory Services, National Kaohsiung Normal University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chang, S C" sort="Chang, S C" uniqKey="Chang S" first="S-C" last="Chang">S-C Chang</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Armstrong, D" sort="Armstrong, D" uniqKey="Armstrong D" first="D" last="Armstrong">D. Armstrong</name>
<affiliation><nlm:affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, P R" sort="Hsueh, P R" uniqKey="Hsueh P" first="P-R" last="Hsueh">P-R Hsueh</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of hospital infection</title>
<idno type="eISSN">1532-2939</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Civil Defense (methods)</term>
<term>Civil Defense (organization & administration)</term>
<term>Communicable Disease Control (methods)</term>
<term>Communicable Disease Control (organization & administration)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (virology)</term>
<term>Pandemics (prevention & control)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Taiwan (epidemiology)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Taiwan</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Civil Defense</term>
<term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Civil Defense</term>
<term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In anticipation of a future pandemic potentially arising from H5N1, H7N9 avian influenza or Middle East Respiratory Syndrome, and in large part in response to severe acute respiratory syndrome (SARS) in 2003, the city of Taipei, Taiwan, has developed extensive new strategies to manage pandemics. These strategies were tested during the 2009 H1N1 outbreak. This article assesses pandemic preparedness in Taipei in the wake of recent pandemic experiences in order to draw lessons relevant to the broader international public health community. Drawing on Taiwan and Taipei Centers for Disease Control data on pandemic response and control, we evaluated the effectiveness of the changes in pandemic response policies developed by these governments over time, emphasizing hospital and medical interventions with particular attention paid to Traffic Control Bundling. SARS and H1N1 2009 catalysed the Taiwan and Taipei CDCs to continuously improve and adjust their strategies for a future pandemic. These new strategies for pandemic response and control have been largely effective at providing interim pandemic containment and control, while development and implementation of an effective vaccination programme is underway. As Taipei's experiences with these cases illustrate, in mitigating moderate or severe pandemic influenza, a graduated process including Traffic Control Bundles accompanied by hospital and medical interventions, as well as school- and community-focused interventions, provides an effective interim response while awaiting vaccine development. Once a vaccine is developed, to maximize pandemic control effectiveness, it should be allocated with priority given to vulnerable groups, healthcare workers and school children. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24996515</PMID>
<DateCompleted><Year>2015</Year>
<Month>03</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2939</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>87</Volume>
<Issue>4</Issue>
<PubDate><Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of hospital infection</Title>
<ISOAbbreviation>J. Hosp. Infect.</ISOAbbreviation>
</Journal>
<ArticleTitle>From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic.</ArticleTitle>
<Pagination><MedlinePgn>185-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2014.05.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0195-6701(14)00156-X</ELocationID>
<Abstract><AbstractText>In anticipation of a future pandemic potentially arising from H5N1, H7N9 avian influenza or Middle East Respiratory Syndrome, and in large part in response to severe acute respiratory syndrome (SARS) in 2003, the city of Taipei, Taiwan, has developed extensive new strategies to manage pandemics. These strategies were tested during the 2009 H1N1 outbreak. This article assesses pandemic preparedness in Taipei in the wake of recent pandemic experiences in order to draw lessons relevant to the broader international public health community. Drawing on Taiwan and Taipei Centers for Disease Control data on pandemic response and control, we evaluated the effectiveness of the changes in pandemic response policies developed by these governments over time, emphasizing hospital and medical interventions with particular attention paid to Traffic Control Bundling. SARS and H1N1 2009 catalysed the Taiwan and Taipei CDCs to continuously improve and adjust their strategies for a future pandemic. These new strategies for pandemic response and control have been largely effective at providing interim pandemic containment and control, while development and implementation of an effective vaccination programme is underway. As Taipei's experiences with these cases illustrate, in mitigating moderate or severe pandemic influenza, a graduated process including Traffic Control Bundles accompanied by hospital and medical interventions, as well as school- and community-focused interventions, provides an effective interim response while awaiting vaccine development. Once a vaccine is developed, to maximize pandemic control effectiveness, it should be allocated with priority given to vulnerable groups, healthcare workers and school children. </AbstractText>
<CopyrightInformation>Copyright © 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yen</LastName>
<ForeName>M-Y</ForeName>
<Initials>MY</Initials>
<AffiliationInfo><Affiliation>Section of Infectious Diseases, Taipei City Hospital, Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. Electronic address: myyen1121@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chiu</LastName>
<ForeName>A W-H</ForeName>
<Initials>AW</Initials>
<AffiliationInfo><Affiliation>Department of Surgery, Taipei City Hospital, Department of Health, Taipei City Government and National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schwartz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Political Science, State University of New York, New Paltz, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>King</LastName>
<ForeName>C-C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lin</LastName>
<ForeName>Y E</ForeName>
<Initials>YE</Initials>
<AffiliationInfo><Affiliation>Center for Environmental Laboratory Services, National Kaohsiung Normal University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>S-C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Armstrong</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hsueh</LastName>
<ForeName>P-R</ForeName>
<Initials>PR</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>06</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Hosp Infect</MedlineTA>
<NlmUniqueID>8007166</NlmUniqueID>
<ISSNLinking>0195-6701</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002959" MajorTopicYN="N">Civil Defense</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H1N1</Keyword>
<Keyword MajorTopicYN="N">Pandemic preparedness</Keyword>
<Keyword MajorTopicYN="N">Severe acute respiratory syndrome</Keyword>
<Keyword MajorTopicYN="N">Six Sigma</Keyword>
<Keyword MajorTopicYN="N">Traffic Control Bundles</Keyword>
<Keyword MajorTopicYN="N">Vaccination campaigns</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>09</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>7</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>7</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24996515</ArticleId>
<ArticleId IdType="pii">S0195-6701(14)00156-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.jhin.2014.05.005</ArticleId>
<ArticleId IdType="pmc">PMC7114835</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 May;10(5):782-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15200809</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biosecur Bioterror. 2007 Mar;5(1):43-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17437351</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Public Health. 2008 Feb 14;8:61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18275603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2003 May 23;52(20):461-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12807078</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2012;7(4):e36120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22545158</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2012 Jun 22;336(6088):1534-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22723413</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Nurs Adm. 2003 Nov;33(11):585-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14608217</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biosecur Bioterror. 2006;4(4):384-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17238822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med J Aust. 1996 Apr 1;164(7):389-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8609844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):923-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20080777</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2010 Aug;16(8):1309-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20678333</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2010 Aug 9;28(35):5703-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20600497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Microbiol Immunol Infect. 2012 Apr;45(2):79-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22483434</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2013 May 16;368(20):1888-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23577628</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2005 Mar;9(2):77-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15708322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Control Hosp Epidemiol. 2007 Mar;28(3):354-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17326030</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect. 2013 Sep;67(3):242-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23623994</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Formos Med Assoc. 2008 Sep;107(9):673-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18796356</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 1993 Jul 21;270(3):350-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8315779</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 2005 Apr;43(4):1651-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15814980</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Curr. 2009 Dec 20;1:RRN1139</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20043033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2013 May 16;18(20):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23725865</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med Hypotheses. 2010 Feb;74(2):240-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19819081</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1997 Dec 19;46(50):1204-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9414153</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2010 Aug 16;28(36):5864-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20600484</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):201-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030683</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2006 Feb;62(2):195-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16153744</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2011 Feb 11;29(8):1605-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21211593</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2011 Apr;77(4):332-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21316802</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 May;10(5):895-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15200825</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2007 Apr 15;44(8):1017-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17366443</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2008 Feb;80(2):316-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18098164</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Public Health. 2008 Jan 18;8:18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18201388</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2010 Oct 21;28(45):7337-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20817013</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Gesundheitswesen. 2009 Jun;71(6):351-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19530059</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Public Health. 2009 May 14;9:142</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19442272</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2009 Nov 23;4(11):e7962</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19956722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2006 Apr 15;367(9518):1239-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16631877</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2011 Apr;17(4):746-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21470479</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 May;10(5):777-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15200808</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:24996515 |texte= From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24996515" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |